| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock |
| (b) | Name of Issuer:
Methanex Corporation |
| (c) | Address of Issuer's Principal Executive Offices:
1800 Waterfront Centre, 200 Burrard Street, Vancouver, BC,
CANADA (FEDERAL LEVEL)
, V6C 3M1. |
Item 1 Comment:
This statement on Schedule 13D relates to the shares of common stock of Methanex Corp, a British Columbia corporation (the "Issuer"). The address of the principal executive offices is: |
| Item 2. | Identity and Background |
|
| (a) | This Schedule 13D is being filed by M&G Investment Management Limited, a company incorporated under the laws of England and Wales (the "Reporting Person"). |
| (b) | The address of the principal business office of the Reporting Person is 10 Fenchurch Avenue, London EC3M 5AG. |
| (c) | The principal business of the Reporting Person is investing in securities. |
| (d) | During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanours). |
| (e) | During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws. |
| (f) | The Reporting Person is a company incorporated under the laws of England and Wales. |
| Item 3. | Source and Amount of Funds or Other Consideration |
| | The funds for the purchase of the Common Stock came from the investment capital of MAGIM. |
| Item 4. | Purpose of Transaction |
| | The Reporting Person acquired the Common Stock to which this Schedule 13D relates for investment purposes in the ordinary course of business. The Reporting Person acquired the Common Stock because they believed that the Common Stock reported herein, when purchased, were undervalued and represented an attractive investment opportunity.
The Reporting Person and their representatives have, from time to time, engaged in, and expect to continue to engage in, discussions with members of management and the board of directors of the Issuer (the "Board"), other current or prospective shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other third parties regarding a variety of matters relating to the Issuer, which may include, among other things, the Issuer's business, management, capital structure and allocation, environmental, social and governance matters, Board composition and strategic alternatives and direction, and may take other steps seeking to bring about changes to increase shareholder value as well as pursue other plans or proposals that relate to or could result in any of the matters set forth in clauses (a)-(j) of Item 4 of Schedule 13D.
The Reporting Person intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions referenced above, the Issuer's financial position, results and strategic direction, actions taken by the Issuer's management and the Board, price levels of the Common Stock, other investment opportunities available to the Reporting Person, conditions in the securities market and general economic and industry conditions, the Reporting Person reserve the right in the future to take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, exchanging information with the Issuer pursuant to appropriate confidentiality or similar agreements; proposing changes in the Issuer's operations, governance or capitalization; acquiring additional Common Stock and/or other equity, debt, notes, instruments or other securities of the Issuer (collectively, "Securities") or disposing of some or all of the Securities beneficially owned by them, in public market or privately negotiated transactions; entering into financial instruments or other agreements that increase or decrease the Reporting Person' economic exposure with respect to their investment in the Issuer; and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D. |
| Item 5. | Interest in Securities of the Issuer |
| (a) | M&G Investment Management Limited (MAGIM) own 11,834,166 shares of Common Stock, which represents approximately 15.30% of 77,364,263 outstanding shares of Common Stock of Methanex, as published by the Issuer on July 28, 2026. |
| (b) | M&G Investment Management has sole voting and investment discretion with respect to the shares |
| (c) | The table below details all transactions since the last 13D filed, on behalf of the Reporting Persons identified above on 30th July 2025, until the date of this filing.
Acquirer/Disposer Trade Date Transaction Type Amount of Shares Price Per Share Where/How Effected
* See separate exhibit for trade details |
| (d) | Both M&G (Lux) Investment Funds 1 and M&G Global Dividend Fund, each a private investment vehicle, for which M&G Investment Management Limited serves as investment adviser, has the right to receive and/or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than five percent of the Common Shares of the Issuer.
To the best knowledge of the reporting person, no person other than the reporting person and those identified above in this Schedule 13D have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned identified herein. |
| (e) | Not applicable |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
| | Not Applicable. |
| Item 7. | Material to be Filed as Exhibits. |
| | Not Applicable. |
